The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.

By R. Jain. Biomaterials, 2000

2,166 citations recorded by the source corpus.

Subfields: Biomaterials, Pharmaceutical Science, Surfaces, Coatings and Films

View Paper: https://www.semanticscholar.org/paper/2e3a25ca16107e63f20e31228c7e140b383ff13c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomaterials

1. F. Danhier
2. I. Rubinstein
3. O. Koo
4. C. Wischke
5. K. O’Connor
6. R. Seeram
7. Ying Zhang
8. K. Leong

In Pharmaceutical Science

1. I. Rubinstein
2. O. Koo
3. C. Wischke
4. Ying Zhang
5. K. Leong
6. V. Préat
7. H. Onyuksel
8. J. Goole

In Surfaces, Coatings and Films

1. C. Wischke
2. K. Leong
3. J. Goole
4. K. Amighi
5. S. Schwendeman

Citations in the corpus

• Advanced Materials and Processing for Drug Delivery: The Past and the Future (2012, background): “Among all, poly (lactic acid) (PLA), poly(glycol acid) (PGA) and their copolymers, poly (lactide-co-glycolide) (PLGA) are the most widely used for DDS development because of their biodegradability, biocompatibility and ease of processing [9,10].”
• Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. (2008, background): “Poly(D,L-lactic-coglycolide), PLGA and its various derivatives have been the center focus for developing nano/microparticles encapsulating therapeutic drugs in controlled release (CR) applications [5–9] due to their inherent advantages over the conventional devices that include extended release rate”
• Preparation and characterization of microspheres based on blend of poly(lactic acid) and poly(ɛ-caprolactone) with poly(vinyl alcohol) as emulsifier (2012, background): “According to Jain, microspheres’ size must be less than 250 lm when they are used for drug delivery system (Jain, 2000) The variation of PVA volumes produces different sizes of microspheres (Fig.”
• Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. (2008, background): “…medium (Lambert and eck, 1995), the formulations became injectable when preformed /o emulsions stored until administration (Jain et al., 2000a,b,c; ain, 2000), or two-compartment systems (syringes attached to ach other with a syringe connector) with its content being disersed at the bedside to…”
• Current progress on bio-based polymers and their future trends (2013, background): “…and Kanchana 2013; Jayanth and Vinod 2012; Nagarwal et al. 2010; Chandy et al. 2000; Valantin et al. 2003 PLGA and copolymers Degradable sutures Rajev 2000 PLA/HA composites Porous scaffolds for cellular applications Jung-Ju et al. 2012 PLA-CaP and PLGA-CaP Bone fixation devices, plates, pins,…”